Objective The key gene and miRNAs in DVT were predicted by bioinformatics methods, and their related pathways were studied to provide new ideas for the diagnosis and treatment of DVT. Methods By analyzing the DATA set GSE17078 of human deep vein thrombosis (DVT) in GEO online database, including 27 normal control cases and 3 DVT cases, the genes with the most significant expression difference were screened as the key gene of DVT. Networkanalyst website was used to perform organ enrichment analysis to check the enrichment of key gene in organs; TargetScan, miRDB and mirTARBASE online databases were used to predict the related miRNAs of key gene, and Venn graph was used to take the intersection of the predicted miRNAs, and the miRNAs with higher correlation were obtained. GO (Gene Ontology) analysis and KEGG (Kyoto Encyclopedia of Genes and Genome) analysis of miRNAs were conducted by mirTARBASE online database. By STRING website, protein-protein Interaction (PPI) network was constructed and GO analysis and KEGG analysis were conducted for the genes of PPI. Finally, through animal experiments, the key gene AP2B1 and its related hsa-miRNA-4780、hsa-miRNA-106b-5p and hsa-miRNA-16-5p were quantitatively analyzed. Results Through differential gene analysis, the key differential gene of DVT was AP2B1 (P = 2.99e-09), which had the highest expression level in human brain. In addition,AP2B1 interacted with other genes mostly in hippocampus. The miRNAs of gene AP2B1 were predicted by online databases, and the most probable miRNAs were hsa-miRNA-4780, hsa-miRNA-106b-5p and hsa-miRNA-16-5p(P<0.05) by Venn diagram. The results showed that hsa-miRNA-4780, hsa-miRNA-106b-5p and hsa-miRNA-16-5p were significantly enriched in 16 signaling pathways, including TGF - β signaling pathway, cell cycle and fatty acid biosynthesis (P < 0.05). Through the PPI construction map of the key gene AP2B1 on the STRING website, it was analyzed that the protein encoded by AP2B1 had complex interactions with 10 proteins such as AP1M1. GO analysis and KEGG analysis illustrated that the protein interaction network genes were enriched in viral defense, receptor metabolism and other functions, and enriched in KEGG pathways such as endocytosis and endocrine related calcium reabsorption. The results of animal experiments confirmed that the expression level of AP2B1 in DVT group was lower than that in control group, while the expression levels of hsa-miRNA-4780, hsa-miRNA-106b-5p and hsa-miRNA-16-5p were higher than that in control group, and the differences were statistically significant. Conclusions By bioinformatics prediction, it is concluded that hsa-miRNA-106b-5p and hsa-miRNA-16-5p might regulate the expression of target gene AP2B1 through TGF-β and other signaling pathways, and participate in the pathophysiological process of DVT, which can be used as new biological diagnostic markers to provide a new idea for the clinical diagnosis and treatment of DVT .
|
[1] Morelli VM, Br?kkan S, Hansen JB. Role of microRNAs in venous thromboembolism[J]. International Journal of Molecular Sciences, 2020, 21(7): 2602. [2]蔣知云,馬俊芬,明亮. microRNA 在深靜脈血栓形成中的作用及臨床價值研究進展[J]. 醫(yī)學研究生學報, 2017, 30(8): 893-896. Jiang ZY, Ma JF, Ming L. Advances in the study of microRNA in deep vein thrombosis[J]. Journal of Medical Postgraduates, 2017, 30(8): 893-896. [3] 褚楚,劉文,郭紅,等. miR-664b-3p調(diào)控Caspase-1介導細胞焦亡在深靜脈血栓形成中的作用[J].山東醫(yī)藥,2021,61(8):20-23. Zhu C, Liu W, Guo H, et al. Regulatory role of miR-664b-3p in caspase-1-mediated pyroptosis in patients with deep vein thrombosis[J].Shandong Medical Journal,2021,61(8):20-23. [4] 馮濤,李晶,潘金強,等. miR-5189-3p在下腔深靜脈血栓形成的調(diào)控機制的研究[J].臨床外科雜志,2021,29(5):478-481. Feng T, Li J, Pan JQ, et al. Study on the regulatory mechanism of miR-5189-3p in deep venous thrombosis of lower extremities [J]. Journal of Clinical Surgery, 2021, 29(5): 478-481. [5]霍艷兵,彭琪,彭星華,等. MicroRNA-374a-5p水平與混合型深靜脈血栓形成患者臨床特征的關系及在預后判斷中的價值[J].中國現(xiàn)代醫(yī)學雜志, 2020, 30(19): 23-28. Huo YB, Peng Q, Peng XH, et al. Clinical characters and prognostic values of microRNA-374a-5p in patients with mixed deep vein thrombosis[J].China Journal of Modern Medicine, 2020, 30(19): 23-28. [6]Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs[J]. Journal of Molecular Medicine, 2011, 89(5): 445-457. [7]Hembrom AA, Srivastava S, Garg I, et al. MicroRNAs in venous thrombo-embolism[J]. Clinica Chimica Acta, 2020, 504: 66–72.? [8] Jiang Z, Ma J, Wang Q, et al. Circulating microRNA expression and their target genes in deep vein thrombosis: a systematic review and bioinformatics analysis[J]. Medicine (Baltimore), 2017, 96(50): e9330. [9] Bijak M, Dzieciol M, Rywaniak J, et al. Platelets miRNA as a prediction marker of thrombotic episodes[J]. Disease Markers, 2016, 2016: 2872507.? [10] Sahu A, Jha PK, Prabhakar A, et al. MicroRNA-145 impedes thrombus formation via targeting tissue factor in venous thrombosis[J]. EBioMedicine, 2017, 26: 175-186. [11]Jiang Z, Ma J, Wang Q, et al. Combination of circulating miRNA-320a/b and D-dimer improves diagnostic accuracy in deep vein thrombosis patients[J]. Medical Science Monitor, 2018, 24: 2031–2037. [12] Du X, Hong L, Sun L, et al. miR-21 induces endothelial progenitor cells proliferation and angiogenesis via targeting FASLG and is a potential prognostic marker in deep venous thrombosis[J]. Journal of Translational Medicine, 2019, 17(1): 270. [13] Thibord F, Munsch G, Perret C, et al. Bayesian network analysis of plasma microRNA sequencing data in patients with venous thrombosis[J]. European Heart Journal Supplements, 2020, 22(Suppl C): C34-C45. [14]高浩然,王巖,段雨晴,等.神經(jīng)重癥患者靜脈血栓栓塞的發(fā)生率、危險因素及住院結局分析[J].中國卒中雜志,2021,16(7):694-698. Gao HR, Wang Y, Duan YQ, et al. Incidence, risk factors and in-hospital outcome of venous thromboembolism in neurocritical patients[J]. Chinese Journal of Stroke, 2021, 16(7): 694-698. [15] Koscielny A, Malik AR, Liszewska E, et al. Adaptor complex 2 controls dendrite morphology via mTOR-dependent expression of GluA2[J]. Molecular Neurobiology, 2018, 55(2): 1590-1606. [16] Suzuki HI. MicroRNA control of TGF-β signaling[J]. International Journal of Molecular Sciences,2018, 19(7):1901. [17]Janakiraman H, House RP, Gangaraju VK, et al. The long (lncRNA) and short (miRNA) of it: TGFβ-mediated control of RNA-binding proteins and noncoding RNAs[J]. Molecular Cancer Research,2018,16(4): 567–579. [18] Sj?din S, Brinkmalm G, ?hrfelt A, et al. Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease[J]. Alzheimer's Research?& Therapy, 2019, 11(1): 82.
|